NO963433L - Middel for transdermal applisering inneholdende desogestrel - Google Patents

Middel for transdermal applisering inneholdende desogestrel

Info

Publication number
NO963433L
NO963433L NO963433A NO963433A NO963433L NO 963433 L NO963433 L NO 963433L NO 963433 A NO963433 A NO 963433A NO 963433 A NO963433 A NO 963433A NO 963433 L NO963433 L NO 963433L
Authority
NO
Norway
Prior art keywords
agent
transdermal application
application containing
containing desogestrel
desogestrel
Prior art date
Application number
NO963433A
Other languages
English (en)
Inventor
Ralph Lipp
Clemens Gunther
Jutta Riedl
Ulrich Tauber
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO963433L publication Critical patent/NO963433L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Et middel for transdermal appli- sering, kjennetegnet ved at det inne- holder desogestrel, eventuelt i kombinasjon med ett eller to østro- gener, og ett eller to blandbare penetrasjonsforsterkende midler i et matrikssystem, men uten tilsetning av krystalliseringsinhibitorer.
NO963433A 1994-02-18 1996-08-16 Middel for transdermal applisering inneholdende desogestrel NO963433L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4405899A DE4405899A1 (de) 1994-02-18 1994-02-18 Mittel zur transdermalen Applikation enthaltend Desogestrel
PCT/EP1995/000481 WO1995022321A1 (de) 1994-02-18 1995-02-09 Mittel zur transdermalen applikation enthaltend desogestrel

Publications (1)

Publication Number Publication Date
NO963433L true NO963433L (no) 1996-08-16

Family

ID=6511045

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963433A NO963433L (no) 1994-02-18 1996-08-16 Middel for transdermal applisering inneholdende desogestrel

Country Status (10)

Country Link
EP (1) EP0744943A1 (no)
JP (1) JPH09508911A (no)
KR (1) KR970701538A (no)
AU (1) AU1578695A (no)
CA (1) CA2183544A1 (no)
DE (1) DE4405899A1 (no)
HU (1) HUT74458A (no)
NO (1) NO963433L (no)
NZ (1) NZ279226A (no)
WO (1) WO1995022321A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
FR2749586B1 (fr) * 1996-06-11 1998-08-07 Hoechst Marion Roussel Inc Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
AU2223600A (en) * 1999-01-06 2000-07-24 Cedars-Sinai Medical Center Hormone replacement for breast cancer patients
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
DE102010040299A1 (de) * 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
BRPI1003661A2 (pt) * 2010-09-15 2013-01-08 Libbs Farmaceutica Ltda associaÇço farmacÊutica para tratar e/ou prevenir mioma e/ou endometriose, uso de resveratrol e progestogenio, composiÇço farmacÊutica para tratamento e/ou prevenÇço de mioma e/ou endometriose medicamento para tratamento e/ou prevenÇço de mioma e/ou endometrios, kit e mÉtodo para tratamento e/ou prevenÇço de mioma e/ou endometriose
JP6345120B2 (ja) * 2012-01-27 2018-06-20 アジル・セラピューティクス・インコーポレイテッドＡｇｉｌｅ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． 経皮ホルモン送達

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
DE4227989A1 (de) * 1992-08-21 1994-06-09 Schering Ag Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel
DE4229820C2 (de) * 1992-09-07 1998-12-03 Jenapharm Gmbh Pharmazeutische Zubereitung auf Gestagen-Basis

Also Published As

Publication number Publication date
DE4405899A1 (de) 1995-08-24
WO1995022321A1 (de) 1995-08-24
HU9602286D0 (en) 1996-10-28
CA2183544A1 (en) 1995-08-24
KR970701538A (ko) 1997-04-12
JPH09508911A (ja) 1997-09-09
HUT74458A (en) 1996-12-30
NZ279226A (en) 1998-05-27
EP0744943A1 (de) 1996-12-04
AU1578695A (en) 1995-09-04

Similar Documents

Publication Publication Date Title
NO307325B1 (no) Middel for transdermal applikasjon inneholdende 3- ketodesogestrel
DK138590D0 (da) Middel til transdermal applikation indeholdende gestoden
NO894367L (no) System og fremgangsmaate for kvantitativ bestemmelse av konsentrasjonene av flere gasser i boreslam.
DK0744944T3 (da) Transdermale terapeutiske systemer indeholdende kønssterioder
AU7099000A (en) Branch instruction for processor
ES2196630T3 (es) Isotiazolcarboxiamidas y su empleo para la proteccion de las plantas.
NO960515D0 (no) Al-Cu-Li legeringer med forbedret kryogen bruddseighet
ES2106888T3 (es) Sistemas terapeuticos transdermicos con inhibidores de la cristalizacion.
HUP0003784A2 (hu) Fájdalmas menstruáció és koraszülés kezelésére alkalmas gyógyászati készítmény
NO963433L (no) Middel for transdermal applisering inneholdende desogestrel
MX9203099A (es) N-heterociclico-n-(4-piperidia)amidas y composiciones farmaceuticas y metodos que emplean dichos compuestos.
DK0817622T3 (da) Transdermalt applicerbart lægemiddel med ACE-hæmmere
HUP9701611A2 (hu) Nagy elektrolittartalmú V/O emulzió, alkalmazása bőrkozmetikai készítményekben, különösen irritáció és/vagy érzékeny bőr kezelésére
BR0007201A (pt) Composições incluindo agentes de preservação demalto-oligossacarìdeos reduzidos, e métodospara preservar um material
NO902111D0 (no) Cyklopropylalkyl- eller -alkenylforbindelser, fremgangsmaate for deres fremstilling og anvendelse derav i flytende krystallinske blandinger.
ES2104133T3 (es) Composiciones cosmeticas o farmaceuticas que contienen glicerofosfolipidos desacilados para uso topico.
DK378988D0 (da) Dopamin-beta-hydroxylaseinhibitorer, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse forbindelser
NO852071L (no) Blodpose med merke som gir forbedret gassgjennomgang.
DE69300069D1 (de) Digitaler Rechnervorgang und arithmetische Einheit zur dessen Ausführung.
DK383183A (da) Biocidt, navnlig fungicidt og/eller bactericidt, middel samt thiosemicarbazoner og metalkomplexer heraf til anvendelse i midlet
NO895141D0 (no) Fremg. for fremst. av fosfororganiske derivater av 2,4-di-t-butylfenol, 4,4'-dihalogenmagnesiumforbindelser av bifenyl og anv. av de fosfororganiske derivatene til stabilisering av kunststoffer, spesielt i polyolefinformmasser.
TR199600117A2 (tr) Ikame edilen benzolsülfonilüre ve tiyoüre, bu maddelerin elde edilmesi ve eczanecilikle ilgili maddelerin bu bilesimler ve bu bilesimleri iceren iyilestirici maddelere dayanarak kullanilmasi ile ilgili usul.
ES2135535T3 (es) Derivados tiazolotriazol y tiazolodiazol con actividad fungicida.
DK0654028T3 (da) 3- og 5-substituerede 1,2,3,4-oxatriazol-5-iminforbindelser og fremgangsmåde til fremstilling deraf, farmaceutisk præparat indeholdende disse forbindelser samt forbindelsernes anvendelse til fremstilling af lægemidler
ATE92795T1 (de) Silizium enthaltender umweltschuetzender wirkstoff, welcher radioaktive metallisotopen und giftige schwere metalle adsorbiert sowie denselben enthaltende pharmazeutische zusammensetzung.